Advertisement
At close: 04:00PM EST
After hours:
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Performance Outlook
| Previous Close | 262.87 |
| Open | 263.89 |
| Bid | 262.59 x 800 |
| Ask | 264.00 x 1200 |
| Day's Range | 259.42 - 266.91 |
| 52 Week Range | 240.50 - 340.11 |
| Volume | |
| Avg. Volume | 1,443,412 |
| Market Cap | 76.924B |
| Beta (5Y Monthly) | 0.66 |
| PE Ratio (TTM) | 14.84 |
| EPS (TTM) | 17.72 |
| Earnings Date | Feb 02, 2024 |
| Forward Dividend & Yield | 4.92 (1.87%) |
| Ex-Dividend Date | Dec 05, 2023 |
| 1y Target Est | 347.81 |
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
6% Est. Return
Subscribe to Yahoo Finance Plus to view Fair Value for CI
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
- The Cigna GroupAnalyst Report: The Cigna GroupCigna primarily provides pharmacy benefit management and health insurance services. Its PBM services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense and it recently won a deal with top-tier insurer Centene. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 18 million U.S. medical members covered as of the end of June 2023.RatingFair ValueEconomic MoatyesterdayMorningstar
Yahoo FinanceWhy the Cigna-Humana deal makes sense: Analysts
Nearly a decade after Cigna and Humana first tried to join forces, the two are at it again.
Investor's Business DailyUnitedHealth, IBD Stock Of The Day, Tops Buy Point As Cigna, Humana Mull Merger
UNH stock cleared a buy point on Thursday, a day after news broke that Cigna and Humana are in talks to create a more formidable rival to UnitedHealth.
ReutersExplainer-Why prior mega health insurer deals like the possible Cigna/Humana merger failed
U.S. health insurers Cigna and Humana are in talks to merge, a potential deal likely to face aggressive scrutiny from the U.S. Justice Department (DOJ) if antitrust history with similarly sized deals is any indication. The DOJ in 2017 successfully stopped Anthem, now Elevance Health, from buying Cigna for $54 billion, and thwarted Aetna's plan to purchase rival Humana for $34 billion.
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.